Company overview
While On May 7th, 2025, the Company entering into an agreement with the Shionogi & Co., Ltd. transfer of the pharmaceutical business and our stake in TORII PHARMACEUTICAL CO., LTD.(''Torii'') a consolidated subsidiary, the JT group's performance and initiatives until 2024 described in this summary include those associated with the pharmaceutical business and Torii.
Please see the press release on our website for the details.
Corporate profile
-
Name
Japan Tobacco Inc.
-
Head office
1-1, Toranomon 4-chome, Minato-ku
Tokyo 105-6927 JAPAN -
Date of establishment
April 1, 1985
-
Paid-in capital
¥100 billion
-
President & CEO
Masamichi Terabatake
-
Number of employees (As of December 31, 2024)
53,593 (Consolidated) / 5,994 (Non-Consolidated)
Revenue (Results in FY 2024)
The JT Group is a leading global tobacco company and our products are sold in over 130 markets. In addition to the tobacco business, we operate pharmaceutical and processed food businesses.
Revenue breakdown by business segment
